These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 35449431)

  • 41. An Audit of Insulin Usage and Insulin Injection Practices in a Large Indian Cohort.
    Baruah MP; Kalra S; Bose S; Deka J
    Indian J Endocrinol Metab; 2017; 21(3):443-452. PubMed ID: 28553603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequency and characteristics of diabetes in lipodystrophies and insulin receptoropathies compared with type 1 and type 2: results from the multicenter DPV registry.
    Kamrath C; Eckert A; Rami-Merhar B; Kummer S; Wabitsch M; Laubner K; Kopp F; Müther S; Mühldorfer S; Holl RW
    Endocr Connect; 2023 Mar; 12(3):. PubMed ID: 36648216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Three-Step Data-Driven Methodology to Assess Adherence to Basal Insulin Therapy in Patients With Insulin-Treated Type 2 Diabetes.
    Nørlev JTD; Kronborg T; Jensen MH; Vestergaard P; Hejlesen O; Hangaard S
    J Diabetes Sci Technol; 2023 Dec; ():19322968231222007. PubMed ID: 38158583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current clinical state of type 1 diabetes in Saitama prefecture.
    Oikawa Y; Hashimoto K; Hara K; Morimoto J; Namai K; Tanaka A; Tanaka S; Shimada A
    Diabetol Int; 2022 Apr; 13(2):436-446. PubMed ID: 35463851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current Perspective on the Potential Benefits of Smart Insulin Pens on Glycemic Control in Patients With Diabetes: Spanish Delphi Consensus.
    Moreno-Fernandez J; Díaz-Soto G; Girbes J; Arroyo FJ
    J Diabetes Sci Technol; 2023 Jun; ():19322968231178022. PubMed ID: 37264627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Developing an automated algorithm for identification of children and adolescents with diabetes using electronic health records from the OneFlorida+ clinical research network.
    Li P; Spector E; Alkhuzam K; Patel R; Donahoo WT; Bost S; Lyu T; Wu Y; Hogan W; Prosperi M; Dixon BE; Dabelea D; Utidjian LH; Crume TL; Thorpe L; Liese AD; Schatz DA; Atkinson MA; Haller MJ; Shenkman EA; Guo Y; Bian J; Shao H
    Diabetes Obes Metab; 2024 Sep; ():. PubMed ID: 39344840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First Real-World Experience With Bigfoot Unity: A 6-Month Retrospective Analysis.
    Baliga BS; Tillman JB; Olson B; Vaughan S; Sheikh FN; Malone JK
    Clin Diabetes; 2023; 41(4):539-548. PubMed ID: 37849519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Starting subcutaneous insulin doses in a paediatric population with newly diagnosed type 1 diabetes.
    Lemieux L; Crawford S; Pacaud D
    Paediatr Child Health; 2010 Jul; 15(6):357-62. PubMed ID: 21731418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of insulin-related lipohypertrophy frequency and risk factors in patients with diabetes.
    Korkmaz FN; Gökçay Canpolat A; Güllü S
    Endocrinol Diabetes Nutr (Engl Ed); 2021 Aug; ():. PubMed ID: 34452876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. STYLCONNECT Study: An Assessment of Automatic Data Collection Devices by People Living with Diabetes and Using an Insulin Pen.
    Naïditch N; Mauchant C; Benabbad I; Hehn C; Joubert M; Thébaut JF; Rosilio M
    Diabetes Ther; 2023 Feb; 14(2):303-318. PubMed ID: 36422803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of the COVID-19 pandemic in diabetes and dyslipidemia management in a Spanish region: a retrospective study of the Aragon population.
    Mateo-Gallego R; Gracia-Rubio I; Garza MC; Cebollada A; Pérez-Calahorra S; Bayona-Sánchez A; Bujeda-Hernández C; Jarauta E; Sánchez-Calavera MA; Lamiquiz-Moneo I
    Front Med (Lausanne); 2023; 10():1191026. PubMed ID: 37484851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors Associated with Controlled Glycemic Levels in Type 2 Diabetes Patients: Study from a Large Medical Center and Its Satellite Clinics in Southeast Region in the USA.
    Nguyen TH; De Leo G; Barefield A
    Healthcare (Basel); 2023 Dec; 12(1):. PubMed ID: 38200932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of people with type 1 diabetes influence the educational process for starting insulin pump therapy: an observational study.
    Izquierdo V; Pazos-Couselo M; González-Rodríguez M; Martínez-Santos AE; Andujar-Plata P; Díaz-Trastoy O; Fernández-Pombo A; Sigüeiro-Paulos S; Rodríguez-González R
    Health Educ Res; 2024 Sep; ():. PubMed ID: 39331003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advancing Patient Safety and Access to Concentrated Insulin (U-500 Regular Insulin) in the Veterans Health Administration: A Clinician Education Program in the Primary Care Setting.
    Lutz-McCain SJ; Bandi A; Larson M
    Clin Diabetes; 2018 Jul; 36(3):244-250. PubMed ID: 30078944
    [No Abstract]   [Full Text] [Related]  

  • 55. Real-world evaluation of vascular complications and comorbidities in Portuguese patients with type 2 diabetes: Results from the cMORE study.
    Bronze L
    Rev Port Cardiol; 2024 Aug; ():. PubMed ID: 39127223
    [No Abstract]   [Full Text] [Related]  

  • 56. Profile of Patients with Diabetes Treated with Insulin Lispro 200 U/ml: A Real-World Study from Spain.
    Rubio de Santos M; Artime E; Duque N; Díaz-Cerezo S; Spaepen E; Carreño Á; Fernández A
    Diabetes Ther; 2022 Jun; 13(6):1147-1160. PubMed ID: 35449431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Which people with diabetes are treated with a disposable, half-unit insulin pen? A real-world, retrospective, database study in Spain.
    Ampudia-Blasco FJ; Duque N; Artime E; Caveda E; Spaepen E; Díaz-Cerezo S; de Santos MR; Velasco DC; Bahíllo-Curieses MP
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e451. PubMed ID: 37715339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient characteristics of insulin lispro 200 units/mL users in real world setting in Germany.
    Schloot NC; Perez-Nieves M; Sapin H; Kruppert S; Otto T; Corrigan SM; Piras de Oliveira C
    Curr Med Res Opin; 2020 Oct; 36(10):1611-1617. PubMed ID: 32845743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An assessment of physician reasons for prescribing Insulin Lispro 200 units/ml in Germany.
    Chen J; Perez-Nieves M; Piras De Oliveira C; Spaepen E; Osumili B; Poon JL; Schloot N; Lara N; Garcia Alvarez L; Roset M
    Postgrad Med; 2020 Nov; 132(8):727-736. PubMed ID: 33108957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
    Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
    Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.